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Abstract
Background: The aim of this study was to compare pregnancy rates in patients undergoing IVF/ICSI with embryo
transfer after 4 and 5 days of culture in a closed incubation system with integrated time-lapse imaging.
Methods: Out of n = 2207 in vitro fertilization (IVF)/ intracytoplasmic sperm injection (ICSI) cycles performed
between January 2011 and April 2016 at a tertiary referral university hospital, a total of n = 599 IVF/ICSI cycles with
prolonged embryo culture in an integrated time-lapse system (EmbryoScope© (Vitrolife)) until day 4 or 5 were
retrospectively analyzed with regard to embryo morphology and pregnancy rates.
Results: A transfer on day 5 compared to a transfer on day 4 did not result in higher implantation and clinical
pregnancy rates (IR 29.4% on day 4 versus 33.0% on day 5, p = 0.310; CPR 45.2% on day 4 versus 45.7% on day 5, p
= 1.0). The percentage of ideal embryos transferred on day 4 was comparable to the rate of ideal embryos
transferred on day 5 (41.6% versus 44.1%, p = 0.508). However, on day 4 a significantly higher number of embryos
was transferred (1.92 on day 4 versus 1.84 on day 5, p = 0.023), which did not result in higher rates of multiple
pregnancies.
Conclusions: Pregnancy rates in IVF/ICSI cycles with integrated time-lapse incubation and transfer on day 4 and 5
are comparable. This finding provides the clinician, IVF laboratory and patient with more flexibility.
Trial registration: This study was retrospectively registered by the local ethics committee of the University of
Heidelberg on December 19, 2016 (registration number S-649/2016).
Keywords: IVF, ICSI, Pregnancy rate, Blastocyst culture, Morphokinetic parameter, embryo selection, Time-lapse
system
Background
The majority of embryo transfers (ETs) after in-vitro-
fertilization (IVF) is performed at cleavage stages on day
2 or 3 after oocyte retrieval. Activation of the embryonic
genome, compaction and blastulation, which are critical
developmental steps, have not taken place at that time
[1–3]. In animal models, the majority of embryos arrest
after transfer to the uterus on day 2 or 3 [2].
Advances in embryo culture conditions, especially the
use of sequential media, have allowed a prolongation of
embryo culture prior to transfer [4, 5]. A blastocyst cul-
ture until day 5, which was first performed in livestock
breeding and later in human IVF, offers the advantage of
selecting embryos which have completed the crucial
steps of compaction and blastulation. Furthermore, an
increase in pregnancy rates (PR) was observed after pro-
longed embryo culture until the blastocyst stage [2, 6–
16]. As a consequence, many IVF units established single
embryo transfers [11].
Time-lapse systems (TLS or TLI = time-lapse imaging)
like the EmbryoScope© may further improve embryo se-
lection while maintaining stable culture conditions [17].
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The impact of TLS on pregnancy and miscarriages rates
is currently a subject of intensive research.
However, blastocyst culture with transfer on day 5 is not
always feasible: embryo transfers sometimes have to be
performed on day 4 instead of day 5 due to organizational
reasons or suboptimal embryogenesis with imminent de-
velopmental arrest or poor embryo quality. In addition,
there is evidence of a higher risk for preterm birth [18],
large for gestational age (LGA)-babies [19], monozygotic
twins [20, 21] and an altered sex ratio [20] as well as con-
cerns about epigenetic alterations and increased congeni-
tal anomalies [22, 23] after prolonged embryo culture.
Thus shorter ex-vivo-intervals may be favorable in order
to minimize neonatal health risks.
Time-lapse imaging might be useful to select embryos
before day 5 in order to minimize these potential risks.
Within this retrospective study we compared embryo
morphology as well as pregnancy rates following single
or multiple embryo transfers on day 4 and day 5 after
cultivation in an integrated time-lapse incubator.
Methods
Study design
All IVF or ICSI cycles from January 2011 to April 2016
with a prolonged embryo culture until day 4 or 5 at a
single university IVF center in Germany were retrospect-
ively analyzed. Only cycles with culture in an integrated
time-lapse incubator (EmbryoScope©, Vitrolife A/S, Aar-
hus, Denmark), embryo transfer and documented HCG
level were included. Frozen-thaw cycles were excluded.
Patients data included maternal age, causes for infertility,
oocyte count, number of fertilized oocytes (pronuclear
stages (PN)), day of transfer, stage and quality of transferred
embryos, application of IVF laboratory techniques (assisted
hatching, calcium ionophore or polar body biopsy), bio-
chemical pregnancy rates, clinical pregnancy rates, presence
of fetal heart beat at completed 6 weeks of gestation and
the number of frozen PN stages and embryos.
Study population
The (long and ultralong) agonist as well as the antagon-
ist protocol were applied and oocyte retrieval was per-
formed 36 h after ovulation induction.
Out of n = 2207 IVF/ICSI cycles a day 4 or 5 transfer
was performed in n = 804 cases. Only cycles with culture
in an integrated time-lapse incubator (EmbryoScope©),
embryo transfer, documented HCG level and outcome
until 6 completed weeks of gestation were included into
the study (n = 599 (27.1%)). In 124 IVF/ICSI cycles the
embryos were transferred on day 4, 475 transfers were
performed on day 5. The decision to transfer the em-
bryo(s) on day 4 instead of day 5 was mainly made for
organizational reasons, for example when day 5 was a
Sunday or public holiday. The German Embryo Protection
Act allows a maximum of 3 embryos to be transferred and
limits the number of embryos to be cultured. The transfer
day was scheduled depending on the number of pro-
nuclear stage oocytes (PNs) available on day 1. In case the
number of available PNs exceeded the number of embryos
to be transferred, prolonged culture until day 5 was sched-
uled with a maximum of 4–5 cultured embryos. Alterna-
tively, day 4 transfer was scheduled in case of
organizational reasons (n = 90/124 day 4 transfers) or
rescheduled to day 4 when only 1–2 embryos were nor-
mally developed at day 3 (n = 34/124 day 4 transfers).
IVF laboratory procedures and embryo morphology
assessment
Cumulus–oocyte–complexes were isolated and rinsed in
Phosphate Buffered Saline (SAGE 4012) supplemented
with 0.05% Heparine (Ratiopharm) followed by washing
in fertilization medium (Sydney IVF©, Cook Medical,
Bloomington, IN, USA) and incubation in fertilization
medium covered under paraffine oil (Origio, Berlin) in
humidified air at 6% CO2 and reduced oxygen (5%) in a
4-well dish. Mature metaphase II (MII) oocytes were in-
seminated by IVF or ICSI. Prior to ICSI oocytes were de-
nuded with hyaluronidase (SynVitro Hyadase©, ORIGIO
GmbH, Berlin). ICSI was performed at an inverted
microscope (Nikon Ti-S©, Tokio, Japan) equipped with a
heated table and micromanipulators (Mikromanipulator
MM89©, Narishige, Tokyo, Japan). Spermatozoa were
placed into polyvinylpyrrolidone solution (PVP Clinical
Grade 10%, Origio, Berlin) in a 60 mm plastic dish
(Nunc Microplate©, Thermo Fisher Scientific Inc. Wal-
tham, MA, USA). In the same dish, oocytes were placed
into drops of gamete medium (Sydney IVF, Cook Med-
ical, Bloomington, IN, USA) and were injected using ap-
propriate micro-capillaries (Micro Injection Pipette© K-
MPIP 1035 and Holding Pipette© K-HPIP 1035, Cook
Medical, Bloomington, IN, USA). In case of previous
fertilization failure or low fertilization rates oocyte activa-
tion by calcium-ionophore (Cult-active Ca-Ionophore©,
Gynemed Medizinprodukte GmbH & Co. KG, Lensahn,
Germany) was applied according to the protocol described
by Tesarik [24] with modifications according to Montag
[25]. Fertilization was assessed 17–19 h after insemination
by the presence of two pronuclei (PNs). Culture of em-
bryos was performed in an EmbryoScope© (Vitrolife) at
37 °C, 6.4% CO2 and 5.0% O2. According to the German
Embryo Protection law and dependent on the previous cy-
cles, patients age as well as oocyte quality a maximum of
4–5 embryos were cultured per patient. Supernumerary
fertilized oocytes were frozen on day 1 at PN stage.
On day 3 the medium was changed by removing cleav-
age and adding blastocyst medium (Cook Medical,
Bloomington, IN, USA). Assisted hatching procedure
was performed in individual cases on day 3 as described
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by Germond [26] with a 1.48 μm diode laser. Embryo
development was described according to the ESHRE
Istanbul Consensus Conference [27], Feil [3] for day 4
embryos and blastocyst development was assessed as de-
scribed by Gardner and Schoolcraft [28].
Two embryos with the best grading and morphokinetic
development were selected for transfer. Occasionally, at
request of the couple or in cases of certain maternal med-
ical conditions, a single embryo was transferred.
Eight patients received three embryos due to implant-
ation failure in past IVF attempts. Well-developed super-
numerary embryos were cryopreserved on the transfer day.
On day 4 an embryo with complete compaction (mor-
ula) was defined as “ideal”, on day 5 blastocysts with
stage 4 or higher and high grades for the inner cell mass
(ICM) and trophectoderm (TE) (AA, AB and BA) quality
were considered morphologically “ideal”. Embryos with
developmental abnormalities (arrest for >24 h and direct
cleavage) were considered as non-ideal albeit matching
the above morphologic criteria on the transfer day.
Pregnancy assessment
Biochemical pregnancies were defined as serum HCG
levels ≥10 IU/l on day 14 after oocyte retrieval. Clinical
pregnancies were determined by ultrasonographic detec-
tion of an intrauterine gestational sac at 5 to 6 weeks of
gestation and ongoing pregnancies were defined as pres-
ence of a fetal heart beat after completed 6 weeks of
gestation. Implantation rates were calculated as de-
scribed by the ICMART committee 2009 [29].
Statistics
Data are presented as mean ± standard error of the mean
or percentage. Statistical analysis was performed by
exact χ2–test (Fisher-Yates-Test) and two-sample un-
paired t-test for independent samples with SPSS 22.0. P-
values <0.05 were considered significant.
Results
Study population
Patient and cycle characteristics are shown in Table 1.
Patient demographics and treatment characteristics in-
cluding mean maternal age, number of oocytes retrieved,
number of injected oocytes in ICSI cycles, number or
fertilized oocytes and rate of cycles with special treat-
ments (i.e. calcium ionophore, polar body biopsy or
assisted hatching) were not significantly different be-
tween the day 4 and day 5 embryo transfer groups.
Comparison of day 4 and day 5 embryo transfer
There was no significant difference between the bio-
chemical (50.0% for day 4 and 53.1% for day 5), clinical
(45.2% for day 4 versus 45.7% for day 5) and ongoing
pregnancy rates (43.5% for day 4 vs 41.7% for day 5) be-
tween embryos transferred on day 4 or 5 (Table 2,
Fig. 1a). Even after exclusion of single and triple embryo
Table 1 Patient characteristics
Patient characteristics Day 4 transfers Day 5 transfers p-value
maternal age (years) 35.3 ± 0.37 35.0 ± 0.21 ns (p = 0.499)
IVF cycles (n) 31 149 –
ICSI cycles (n) 91 305 –
cycles with splitting IVF/ICSI (n) 2 21 –
oocytes (n) 11.02 ± 0.46 10.91 ± 0.24 ns (p = 0.826)
mature oocytes (MII) in ICSI cycles (n) 8.83 ± 0.45 8.67 ± 0.23 ns (p = 0.743)
PN/cycle 6.44 ± 0.28 6.16 ± 0.13 ns (p = 0.343)
cycles with calcium ionophore 9 (7.3%) 40 (8.4%) ns (p = 0.854)
cycles with assisted hatching 6 (4.8%) 23 (4.8%) ns (p = 1.0)
cycles with polar body biopsy 7 (5.6%) 12 (2.5%) ns (p = 0.087)
no of transferred embryos SET: N = 12
DET: N = 110
TET: N = 2
SET: N = 82
DET: N = 387
TET: N = 6
s for SET (p = 0.038)
ns for DET (p = 0.061)
ns for TET (p = 0.673)
mean no of transferred embryos 1.92 ± 0.03 1.84 ± 0.02 s (p = 0.023)
transferred ideal embryos 99/238 (41.6%) 385/874 (44.1%) ns (p = 0.508)
transferred embryos with timely developmental
stage (day 4 =morula; day 5 = blastocyst)
99/238 (41.6%) 809/874 (92.9%) s (p < 0.001)
frozen PN/cycle 2.04 ± 0.26 1.81 ± 0.12 ns (p = 0.388)
frozen embryos/cycle 0.32 ± 0.06 0.37 ± 0.03 ns (p = 0.462)
Values are given as mean ± SEM or % (n/total), unless otherwise indicated; SET single embryo transfer, DET double embryo transfer, TET triple embryo transfers, ns
non-significant, s significant (p < 0.05)
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Table 2 Pregnancy rates by day of embryo transfer
Day 4 transfers Day 5 transfers p-value
positive pregnancy test/ embryo transfer 62/124 (50.0%) 252/475 (53.1%) ns (p = 0.547)
positive pregnancy test/ embryo transfer after transfer of 1 embryo 3/12 (25.0%) 30/82 (36.6%) ns (p = 0.531)
positive pregnancy test/ embryo transfer after transfer of 2 embryos 58/110 (52.7%) 220/387 (56.8%) ns (p = 0.448)
positive pregnancy test/ embryo transfer after transfer of 3 embryos 1/2 (50.0%) 2/6 (33.3%) ns (p = 1.0)
clinical pregnancy/ embryo transfer 56/124 (45.2%) 217/475 (45.7%) ns (p = 1.0)
clinical pregnancy/ embryo transfer after transfer of 1 embryo 3/12 (25.0%) 25/82 (30.5%) ns (p = 1.0)
clinical pregnancy/ embryo transfer after transfer of 2 embryos 52/110 (47.3%) 190/387 (49.1%) ns (p = 0.747)
clinical pregnancy/ embryo transfer after transfer of 3 embryos 1/2 (50.0%) 2/6 (33.3%) ns (p = 1.0)
ongoing pregnancy/ embryo transfer 54/124 (43.5%) 198/475 (41.7%) ns (p = 0.759)
ongoing pregnancy/ embryo transfer after transfer of 1 embryo 3/12 (25.0%) 21/82 (25.6%) ns (p = 1.0)
ongoing pregnancy/ embryo transfer after transfer of 2 embryos 50/110 (45.5%) 175/387 (45.2%) ns (p = 1.0)
ongoing pregnancy/ embryo transfer after transfer of 3 embryos 1/2 (50.0%) 2/6 (33.3%) ns (p = 1.0)
multiple pregnancies with > 1 positive heart beat after 6 weeks 11/124 (8.9%)
Twins: N = 11
Triplets: N = 0
62/475 (13.1%)
Twins: N = 61
Triplets: N = 1
ns (p = 0.280)
implantation rate per embryo (no of gestational sacs/no of transferred embryos) 70/238 (29.4%) 288/874 (33.0%) ns (p = 0.310)
ns non-significant, s significant (with p < 0.05)
a
b
Fig. 1 a Comparison of clinical and ongoing pregnancy rates of day 4 and day 5 embryo transfers. Error bars indicate 95% confidence intervals. b
Pregnancy rates in correlation to the number of transferred embryos. SET = single embryo transfer; DET = double embryo transfer; TET = triple
embryo transfer. Error bars indicate 95% confidence interval
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transfers, the pregnancy rates of both transfer days were
comparable (Table 2, Fig. 1b). Additionally, no signifi-
cant difference between the implantation rates after day
4 transfers and day 5 transfers could be observed (29.4%
versus 33.0% with p = 0.310).
The rate of ideal embryos transferred did not differ
significantly between both groups (41.6% on day 4
versus 44.1% on day 5, p = 0.508, Fig. 2a). However,
the mean number of embryos transferred on day 4
was higher than on day 5 (1.92 vs 1.84, p = 0.023),
a
b
c
Fig. 2 a Percentage of ideal (good quality) embryos transferred on day 4 and 5. Error bars indicate 95% confidence intervals. b Percentage of
embryos transferred on day 4 and day 5 with timely development (according to [27]). Error bars indicate 95% confidence intervals. c
Developmental distribution of embryos transferred on day 4 and 5. Day 4 = cycles with embryo transfer on day 4; Day 5 = cycles with
embryo transfer on day 5
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but the lower number of transferred embryos on day
5 did not lead to significant changes in the rate of
ongoing multiple pregnancies (Table 2).
The mean number of cryopreserved embryos was
comparable between both groups (Table 1: 0.32 em-
bryos/cycle on day 4 vs. 0.37 on day 5).
Discussion
A prolonged embryo culture beyond day 3 with transfer of
a blastocyst results in a higher implantation rate, possibly
due to improved possibilities to judge developmental com-
petence based on enhanced assessment of morphology
[30]. It can also give the embryologist time for a preimplan-
tation genetic analysis of polar bodies or trophectoderm if
needed [31, 32]. However, an extended embryo culture is
not beneficial when embryo selection is not possible [33].
In our study, we compared the outcome of IVF/ICSI
cycles with a prolonged embryo culture in an integrated
time-lapse culture system and transfer on day 4 to trans-
fer on day 5. In a cohort of 599 transfer cycles, the clin-
ical and ongoing pregnancy rate did not differ
significantly between the two groups.
Key disadvantages of a day 4 or 5 culture are a higher
cycle cancellation rate, possible epigenetic influences
[22] and an increased risk for monozygotic twins [34–
36]. The potential negative effect of a longer culture on
embryo quality might be caused by an increased expos-
ure of embryos outside the incubator [37], but can be re-
duced when using closed incubation systems with
constant and undisturbed culture conditions (e.g.
EmbryoScope©) [30].
Usually, a prolonged embryo culture means cultivation
until the blastocyst stage on day 5. But organizational
reasons (e.g. weekend / public holidays) can lead to the
decision to transfer on day 4 instead of day 5.
Current literature evaluating day 4 transfers de-
scribes advantages compared to day 2 or 3 transfers
[38–41] and no significant difference between day 4
and day 5 transfers with regard to single embryo
transfers (SET) [3]. The largest prospective study
comparing culture durations of 3 to 5 days in a
single-step medium showed comparable pregnancy
rates in all groups [9] with pregnancy rates of 25.8%
after day 4 transfers (n = 475) and 27.8% after day 5
transfers (n = 694). In a Korean retrospective analysis
of 440 IVF cyles with day 4 and 307 cycles with day
5 transfers also no significant difference in pregnancy
rates was present [42].
Our study supports the current literature that embryo
culture until day 4 seems not to have disadvantages to a
5-days culture, providing more flexibility to clinicians,
laboratory staff and patients. Apart from organizational
reasons there are other advantages of a 4-days instead of
5-days culture:
1) Transfer on day 4 means that the embryos are
placed in the uterine cavity at a time when they are
naturally designed to reach the uterus and when
uterine contractility is already reduced [43, 44].
2) A shorter time interval in vitro may also reduce the
risk of genetic/epigenetic alterations, fetal
malformations, monozygotic twinning and preterm
birth associated with blastocyst culture [23].
Our study power is slightly limited by the different
sample size of the day 4 and 5 study population sub-
groups (80% of the transfers were day 5 transfers). But
this is the first time that pregnancy rates of day 4 and
day 5 transfers are compared after cultivation in an inte-
grated time-lapse incubator which ensures very stable
culture conditions and can help to identify the most cap-
able embryos by morphokinetic characteristics. In con-
trast to Lee et al. [42], who made the decision for day 4
transfers in cases of suboptimal culture conditions and
therefore transferred a significantly lower percentage of
good quality embryos on day 4, we made the decision to
transfer on day 4 in the majority of cases already on day
1 in case day 5 was a Sunday or public holiday. There-
fore, the bias of suboptimal culture conditions in day 4
transfers was strongly reduced.
Apart from comparable pregnancy rates, we also ob-
served comparable rates of multiple pregnancies after
day 4 and day 5 transfers despite a significantly higher
number of transferred embryos on day 4 (Table 1,
Fig. 1a). Therefore, we calculated the implantation rate
per embryo and found that it was slightly lower after a
day 4 transfer in comparison to a day 5 transfer (29.4%
versus 33.0%, without reaching statistical significance (p
= 0.310). This finding can be interpreted as evidence that
the extended culture of embryos to day 5 enables further
de-selection of non-ideal embryos.
Conclusions
In conclusion, the use of day 4 ETs in non-selected cou-
ples results in acceptable pregnancy rates with no differ-
ence between day 4 and day 5 transfers in TLS cycles.
Therefore, the decision when to perform the embryo
transfer in cycles with a prolonged culture can be based
on clinic, patient and IVF laboratory requirements.
Abbreviations
CPR: Clinical pregnancy rate; ET: Embryo transfer; ICM: Inner cell mass of the
embryo; ICSI: Intracytoplasmatic sperm injection; IR: Implantation rate; IVF: In-
vitro-fertilization; TE: Trophectoderm; TLI: Time-lapse imaging; TLS: Time-lapse
system
Acknowledgements
The authors thank the medical and technical staff of the Department of
Gynecological Endocrinology and Reproductive Medicine of the University of
Heidelberg. We thank Armin Holschbach (Faculty of Mathematics, University
of Heidelberg) for advice in statistical analysis.
Holschbach et al. Reproductive Biology and Endocrinology  (2017) 15:37 Page 6 of 8
Funding
We acknowledge financial support by Deutsche Forschungsgemeinschaft
and Ruprecht-Karls-Universität Heidelberg within the funding programme
Open Access Publishing.
Availability of data and materials
The datasets analysed during the current study are available from the
corresponding author on reasonable request.
Authors’ contributions
BT and VH were involved in the design and conception of the study. JW
accumulated the data. VH performed data analyses (with support of AH),
interpretation of the data and writing of the manuscript. MM, TS and JED
contributed to editorial revisions. All authors read the manuscript critically
and gave final approval of this manuscript.
Competing interests
Markus Montag is CEO of a consultancy company (ilabcomm GmbH), which
received honorarium for consultancy from Vitrolife. The other authors declare
no potential conflicts of interest with respect to the research, authorship,
and/or publication of this article.
Consent for publication
Not applicable.
Ethics approval and consent to participate
The protocol was approved by the local ethics committee of the University
of Heidelberg (study number S-649/2016, Dec 19, 2016). All procedures were
performed according to the Helsinki declaration on Human Experimentation.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Gynaecological Endocrinology and Fertility Disorders,
Ruprecht- Karls University Heidelberg, Im Neuenheimer Feld 440, 69120
Heidelberg, Germany. 2ilabcomm GmbH, Eisenachstr. 34, 53757 Sankt
Augustin, Germany. 3Gynecological Endocrinology and Reproductive
Medicine, University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.
Received: 13 February 2017 Accepted: 24 April 2017
References
1. Braude P, Bolton V, Moore S. Human gene expression first occurs between
the four- and eight-cell stages of preimplantation development. Nature.
1988;332(6163):459–61.
2. Gardner DK, Lane M, Schoolcraft WB. Physiology and culture of the human
blastocyst. J Reprod Immunol. 2002;55(1-2):85–100.
3. Feil D, Henshaw RC, Lane M. Day 4 embryo selection is equal to day 5
using a new embryo scoring system validated in single embryo transfers.
Hum Reprod. 2008;23(7):1505–10.
4. Chatot CL, et al. An improved culture medium supports development of
random-bred 1-cell mouse embryos in vitro. J Reprod Fertil. 1989;86(2):679–88.
5. Gardner DK, Lane M. Culture and selection of viable blastocysts: a feasible
proposition for human IVF? Hum Reprod Update. 1997;3(4):367–82.
6. Menezo Y, et al. Coculture of embryos on Vero cells and transfer of
blastocysts in humans. Hum Reprod. 1992;7 Suppl 1:101–6.
7. Olivennes F, et al. Four indications for embryo transfer at the blastocyst
stage. Hum Reprod. 1994;9(12):2367–73.
8. Huisman GJ, et al. A comparison of in vitro fertilization results after embryo
transfer after 2, 3, and 4 days of embryo culture. Fertil Steril. 1994;61(5):970–1.
9. Huisman GJ, et al. Implantation rates after in vitro fertilization and transfer
of a maximum of two embryos that have undergone three to five days of
culture. Fertil Steril. 2000;73(1):117–22.
10. Scholtes MC, Zeilmaker GH. A prospective, randomized study of embryo
transfer results after 3 or 5 days of embryo culture in in vitro fertilization.
Fertil Steril. 1996;65(6):1245–8.
11. Gardner DK, et al. Culture and transfer of human blastocysts increases
implantation rates and reduces the need for multiple embryo transfers.
Fertil Steril. 1998;69(1):84–8.
12. Jones GM, et al. Evolution of a culture protocol for successful blastocyst
development and pregnancy. Hum Reprod. 1998;13(1):169–77.
13. Jones GM, et al. Factors affecting the success of human blastocyst
development and pregnancy following in vitro fertilization and embryo
transfer. Fertil Steril. 1998;70(6):1022–9.
14. Summers MC, Biggers JD. Chemically defined media and the culture of
mammalian preimplantation embryos: historical perspective and current
issues. Hum Reprod Update. 2003;9(6):557–82.
15. Glujovsky D, et al. Cleavage stage versus blastocyst stage embryo transfer in
assisted reproductive technology. Cochrane Database Syst Rev. 2012;7:
CD002118.
16. Kaur P, et al. A comparative study between cleavage stage embryo transfer
at day 3 and blastocyst stage transfer at day 5 in in-vitro fertilization/intra-
cytoplasmic sperm injection on clinical pregnancy rates. J Hum Reprod Sci.
2014;7(3):194–7.
17. Armstrong S, et al. Time-lapse systems for embryo incubation and
assessment in assisted reproduction. Cochrane Database Syst Rev. 2015;2:
CD011320.
18. Maheshwari A, et al. Obstetric and perinatal outcomes in singleton
pregnancies resulting from the transfer of blastocyst-stage versus cleavage-
stage embryos generated through in vitro fertilization treatment: a
systematic review and meta-analysis. Fertil Steril. 2013;100(6):1615–21. e1-10.
19. Zhu J, et al. Effect of in vitro culture period on birthweight of singleton
newborns. Hum Reprod. 2014;29(3):448–54.
20. Chang HJ, et al. Impact of blastocyst transfer on offspring sex ratio and the
monozygotic twinning rate: a systematic review and meta-analysis. Fertil
Steril. 2009;91(6):2381–90.
21. Luke B, et al. Factors associated with monozygosity in assisted reproductive
technology pregnancies and the risk of recurrence using linked cycles. Fertil
Steril. 2014;101(3):683–9.
22. Dar S, et al. Neonatal outcomes among singleton births after blastocyst
versus cleavage stage embryo transfer: a systematic review and meta-
analysis. Hum Reprod Update. 2014;20(3):439–48.
23. Maheshwari A, Hamilton M, Bhattacharya S. Should we be promoting embryo
transfer at blastocyst stage? Reprod Biomed Online. 2016;32(2):142–6.
24. Tesarik J, Sousa M, Mendoza C. Sperm-induced calcium oscillations of
human oocytes show distinct features in oocyte center and periphery. Mol
Reprod Dev. 1995;41(2):257–63.
25. Montag M, et al. The benefit of artificial oocyte activation is dependent on
the fertilization rate in a previous treatment cycle. Reprod Biomed Online.
2012;24(5):521–6.
26. Germond M, et al. Microdissection of mouse and human zona pellucida
using a 1.48-microns diode laser beam: efficacy and safety of the procedure.
Fertil Steril. 1995;64(3):604–11.
27. Alpha Scientists in Reproductive, M, E.S.I.G.o. Embryology. The Istanbul
consensus workshop on embryo assessment: proceedings of an expert
meeting. Hum Reprod. 2011;26(6):1270–83.
28. Gardner DK. In vitro culture of human blastocysts. In: Jansen R, editor.
Towards reproductive certainty: fertility and genetics beyond. Carnforth:
Parthenon Press; 1999. p. 378–88.
29. Zegers-Hochschild F, et al. The International Committee for Monitoring
Assisted Reproductive Technology (ICMART) and the World Health
Organization (WHO) Revised Glossary on ART Terminology, 2009. Hum
Reprod. 2009;24(11):2683–7.
30. Rubio I, et al. Clinical validation of embryo culture and selection by
morphokinetic analysis: a randomized, controlled trial of the EmbryoScope.
Fertil Steril. 2014;102(5):1287–94. e5.
31. Grifo JA, et al. Successful outcome with day 4 embryo transfer after
preimplantation diagnosis for genetically transmitted diseases. Hum Reprod.
1998;13(6):1656–9.
32. Gianaroli L, et al. Advantages of day 4 embryo transfer in patients
undergoing preimplantation genetic diagnosis of aneuploidy. J Assist
Reprod Genet. 1999;16(4):170–5.
33. Montag M, et al. Extended embryo culture reduces the implantation rate on day
4 and day 5 when only a maximum of three embryos are cultured beyond the
pronuclear stage. Eur J Obstet Gynecol Reprod Biol. 2006;124(1):65–9.
34. Behr B, et al. Blastocyst-ET and monozygotic twinning. J Assist Reprod
Genet. 2000;17(6):349–51.
Holschbach et al. Reproductive Biology and Endocrinology  (2017) 15:37 Page 7 of 8
35. da Costa AA, et al. Monozygotic twins and transfer at the blastocyst stage
after ICSI. Hum Reprod. 2001;16(2):333–6.
36. Tarlatzis BC, et al. Increase in the monozygotic twinning rate after
intracytoplasmic sperm injection and blastocyst stage embryo transfer. Fertil
Steril. 2002;77(1):196–8.
37. Zhang JQ, et al. Reduction in exposure of human embryos outside the
incubator enhances embryo quality and blastulation rate. Reprod Biomed
Online. 2010;20(4):510–5.
38. Tao J, et al. The neglected morula/compact stage embryo transfer. Hum
Reprod. 2002;17(6):1513–8.
39. Margreiter M, et al. A prospective randomized multicenter study to evaluate
the best day for embryo transfer: does the outcome justify prolonged
embryo culture? J Assist Reprod Genet. 2003;20(2):91–4.
40. Skorupski JC, et al. Successful pregnancy rates achieved with day 4 embryo
transfers. Fertil Steril. 2007;87(4):788–91.
41. Pantos K, et al. Day 4 versus day 3 embryo transfer: a prospective study of
clinical outcomes. Fertil Steril. 2008;89(3):573–7.
42. Lee SH, et al. Comparison of the clinical outcomes of day 4 and 5 embryo
transfer cycles. Clin Exp Reprod Med. 2013;40(3):122–5.
43. Fanchin R, et al. Uterine contractions at the time of embryo transfer alter
pregnancy rates after in-vitro fertilization. Hum Reprod. 1998;13(7):1968–74.
44. Lesny P, et al. Uterine junctional zone contractions during assisted
reproduction cycles. Hum Reprod Update. 1998;4(4):440–5.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Holschbach et al. Reproductive Biology and Endocrinology  (2017) 15:37 Page 8 of 8
